Market Place
Sourcing Support
Tonix Pharma Announces TONMYA PK After 20 Days of Daily Dosing
15 Apr 2026 //
GLOBENEWSWIRE
Tonix Presents Phase 1 TNX-4800 Data for Lyme Disease Prevention
31 Mar 2026 //
GLOBENEWSWIRE
Tonix Pharma Initiates Ph1 Study Of TNX-1900 For Migraine Pain
26 Mar 2026 //
GLOBENEWSWIRE
Tonix Pharma Presents At World Vaccine Congress Washington 2026
23 Mar 2026 //
GLOBENEWSWIRE
Tonix Pharmaceuticals To Present At Bio-Europe Spring 2026
18 Mar 2026 //
GLOBENEWSWIRE
Tonix To Present Immuno-Oncology Data At AACR 2026
17 Mar 2026 //
GLOBENEWSWIRE
Tonix: Post-Hoc Phase 3 TONMYA Analyses at 8th Fibro Congress
10 Mar 2026 //
GLOBENEWSWIRE
Tonix Pharma to Present TONMYA Data at 2026 AAPM Annual Meeting
09 Mar 2026 //
GLOBENEWSWIRE
Tonix Pharma To Present Tonmya Poster At 2026 Aapm Painconnect
03 Mar 2026 //
GLOBENEWSWIRE
Tonix Pharma: Resilient Tonmya Data at 2026 Pain Conference
30 Jan 2026 //
GLOBENEWSWIRE
Tonix Pharma To Present At 2 Investor Conferences In Jan 2026
06 Jan 2026 //
GLOBENEWSWIRE
Tonix Pharma Reveals Phase 2/3-Ready Long-Acting Antibody
29 Dec 2025 //
GLOBENEWSWIRE
Tonix Pharma Licenses TNX-4900, For Chronic Neuropathic Pain
16 Dec 2025 //
GLOBENEWSWIRE
FDA Clears Tonix IND for TNX-102 SL Phase 2 in MDD
24 Nov 2025 //
GLOBENEWSWIRE
Tonix Pharma Reveals Q3 2025 Financials And Operations Update
10 Nov 2025 //
GLOBENEWSWIRE
Tonix Pharma Unveils Tonmya Data at 2025 ACR Conference
27 Oct 2025 //
GLOBENEWSWIRE
Tonix Dose 1st Patient in MGH-Led Study of Oxytocin in AVP-D
22 Oct 2025 //
GLOBENEWSWIRE
Tonix Pharma To Present Tonmya™ Poster At 2025 ACR Conference
21 Oct 2025 //
GLOBENEWSWIRE
Tonix Pharma Unveils TNX-801 Mpox Vaccine Data At World Vaccine
17 Oct 2025 //
GLOBENEWSWIRE
Tonix Pharma Updates TNX-1500, At Japan Transplantation Congress
14 Oct 2025 //
GLOBENEWSWIRE
Tonix Pharma To Present At World Vaccine Congress, Europe 2025
09 Oct 2025 //
GLOBENEWSWIRE
Tonix Pharma Reports Favorable Pre-IND Meeting with FDA
18 Sep 2025 //
GLOBENEWSWIRE
Tonix In-licenses Ph 2/3 mAb TNX-4800 For Lyme Disease Prevention
17 Sep 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Join Fireside Chat at Cantor Conference
28 Aug 2025 //
GLOBENEWSWIRE
FDA Approves Tonix`s Tonmya™ for Fibromyalgia Treatment
15 Aug 2025 //
GLOBENEWSWIRE
Tonix Pharma Launches `Move Fibro Forward` Fibromyalgia Campaign
21 Jul 2025 //
GLOBENEWSWIRE
Tonix Presents New Data on Mpox, TNX-801 Smallpox Vaccine
10 Jul 2025 //
GLOBENEWSWIRE
Tonix Presents Mpox, Smallpox Vaccine Tnx-801 Data at Vaccine
07 Jul 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Publication in Journal
02 Jul 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Included in Russell 3000® and 2000®
30 Jun 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at BIO International 2025
10 Jun 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present Poster at Eular 2025
05 Jun 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Presents Data on Mpox Vaccine TNX-801
24 Apr 2025 //
GLOBENEWSWIRE
Tonix and Makana Collaborate on Xenotransplantation Studies
09 Apr 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at Zacks SCR Life Sciences
11 Mar 2025 //
GLOBENEWSWIRE
Tonix Pharma Gets MCDC Grant For TNX-801 Mpox, Smallpox Vaccine
10 Mar 2025 //
GLOBENEWSWIRE
Tonix Report Positive Ph 1 Result for TNX-1500 in Kidney Transplant
06 Feb 2025 //
GLOBENEWSWIRE
Tonix Pharma Publishes Mpox & Smallpox Vaccine Study in mSphere
13 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma Announces Mpox Phase I Study Agreement with KEMRI
04 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals To Present At World Vaccine Congress
24 Oct 2024 //
GLOBENEWSWIRE
Tonix Pharma Joins Endpoints Panel At Long COVID Workshop
30 Sep 2024 //
GLOBENEWSWIRE
Tonix`s Mpox Vaccine Aligns With WHO`s Target Profile
16 Sep 2024 //
GLOBENEWSWIRE
Tonix Presents Data On Potential Mpox Vaccine TNX-801
09 Sep 2024 //
GLOBENEWSWIRE
Tonix and Bilthoven Collaborate on Mpox Vaccine Development, TNX-801
26 Aug 2024 //
GLOBENEWSWIRE
Tonix And Bilthoven Biologicals To Collaborate On Mpox Vaccine Development
26 Aug 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Presentations Involving TNX-1500 At ATC 2024
06 Jun 2024 //
GLOBENEWSWIRE
Tonix Presents TNX-1500 Data At American Transplant Congress 2024
29 May 2024 //
GLOBENEWSWIRE
Tonix Announces Presentation Discovery of Oxytocin Analogues at the ACS Meeting
21 Mar 2024 //
GLOBENEWSWIRE
Tonix Announces Translation of Pharmacokinetic Parameters of TNX-1500
05 Mar 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500
28 Feb 2024 //
GLOBENEWSWIRE
Tonix Candidate, TNX-1800, Selected by NextGen for Inclusion in Trials
02 Nov 2023 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces New Data Involving TNX-1500
30 Oct 2023 //
GLOBENEWSWIRE
Tonix Presents Data from its Horsepox-Based Vaccine Development Platform
19 Oct 2023 //
GLOBENEWSWIRE
Tonix Announces Publication of Data in the Journal Nature Involving TNX-1500
18 Oct 2023 //
GLOBENEWSWIRE
Tonix Announces Oral Presentation at the World Vaccine Congress Europe
11 Oct 2023 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Poster Presentation Involving TNX-1700
14 Sep 2023 //
GLOBENEWSWIRE
Tonix`s long COVID drug fails to meet mid-stage trial goal
06 Sep 2023 //
REUTERS
Tonix Pharmaceuticals Initiates Phase 1 Trial of TNX-1500 in Healthy Volunteers
16 Aug 2023 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Data Presentations Involving TNX-1500
07 Jun 2023 //
GLOBENEWSWIRE
